Johnson & Johnson is one of the largest health care conglomerates worldwide, boasting pharmaceutical and consumer health divisions that produce megabrands such as Tylenol and Band-Aids. However, innovation goes well beyond these products alone for this company.
Vice Chairman Joaquin Duato oversees J&J in an ever-evolving world, helping lead them through each transition and rapid change. Techonomy recently caught up with him to learn more about its approach.
1. Focus on Innovation
Established by three visionary brothers Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson in 1886, Johnson & Johnson is currently one of the world’s most valuable publicly traded companies. Their pharmaceutical and medical devices businesses generate $77 billion each year in revenues alone – making them one of the leading makers of drugs, vaccines, surgical tools etc.
Although most people associate J&J with consumer goods such as Band-Aids, Listerine, Tylenol and other consumer items, these comprise only a relatively minor part of its revenue stream. Most of its profits come from its pharmaceutical and medical device divisions that produce anti-inflammatory medicines to cancer treatments to blood thinners to robotic knee replacement systems – among many other things.
J&J’s brand identity centers around a central theme: “Innovating for Life.” The company strives to develop healthcare innovations that are smarter, less invasive and more personalized. Their Medical Technology division in particular is working hard to tackle some of healthcare’s toughest issues through groundbreaking technologies that operate at the intersection of biology and technology. Furthermore, through JLABS the company invests in business startups that showcase innovative ideas as well as invests in their development through an innovation incubator program.
An agile operating model allows the company to adapt quickly to changes in healthcare industry, for instance in recent years they implemented a strategy of purchasing smaller companies on the verge of major breakthroughs, which expanded their pipeline with treatments for diseases that affect immunity such as viral diseases and oncology.
J&J utilizes its global network of research and development centers to quickly bring new products to market. These facilities, located around the globe, work together as one to form a unified platform that meets patient needs globally, as well as serve as hubs for collaborations with other companies to speed up product development and market access – for instance they recently announced a partnership agreement with Toronto-based MaRS Innovation focused on advancing early stage technologies that may benefit their businesses.
2. Flexibility in Operating Model
Johnson & Johnson is one of the world’s largest healthcare companies, with a vast and diversified product range that spans consumer items like Band-Aid bandages and Listerine mouthwash to pharmaceuticals such as antidepressants and cancer drugs, medical devices like stents and orthopedic implants. Furthermore, its charitable initiatives such as partnerships with FHI 360 and Junior Achievement to advance STEM education as well as women in business are recognized worldwide.
Its flexible operating model has allowed it to expand its presence within healthcare industry and remain an influential player. It can acquire businesses at the brink of major breakthroughs or run lean and efficient operations by creating its own innovation pipeline – an approach which has allowed it to remain a leading player even during economic downturns.
J&J remains true to its 1943 credo, which outlines its responsibility towards patients/physicians/employees/communities and shareholders. Leadership and managers consistently test new ideas against this credo to make sure they fit with its corporate philosophy – this process, known as Credo Challenges, is often practiced during J&J leadership and employee meetings.
Future expectations indicate that J&J will likely maintain its innovation and expansion across its existing markets while exploring expansion into new ones. Furthermore, it may seek opportunities to collaborate with other global healthcare leaders – including start-ups and academic institutions – on collaborative ventures.
As healthcare continues to transform at an unprecedented pace, Johnson & Johnson stands ready to adapt. The company stands to lead with innovation and its charitable legacy as proof of their dedication to bettering human health.
J&J is in an ideal position to continue its transformation into one of the leading global healthcare companies, boasting a robust innovation pipeline and diverse business portfolio. Leveraging its strengths across pharmaceuticals and medical devices to form an even stronger global leader that can better provide patients and physicians with innovative, comprehensive and integrated solutions that drive improved health outcomes is its goal.
3. Adaptability in Supply Chain
Johnson & Johnson is one of the world’s largest health care companies, boasting iconic household brand names from Band-Aid plasters to Listerine mouthwash and Tylenol painkillers. Based in New Jersey, they also possess an expansive medical devices business. As of November 2021, the New Jersey company revealed plans to focus solely on pharmaceuticals and medical device businesses while spinning off consumer products division.
J&J has long operated under its Credo, an organizational document written by its founder and namesake, John Jenkins. This philosophy holds that employees of J&J must prioritize serving patients above coworkers or communities they serve, which has propelled innovation within the firm, including medicated plasters that deliver treatments directly onto skin surfaces, as well as cutting-edge production methods that streamline sterilized surgical instrument production more efficiently.
Healthcare has undergone many significant disruptions, yet the firm has stayed true to its strategic north star of being an active corporate citizen and trusted partner. They do this largely thanks to flexible supply chains which can adjust quickly when healthcare changes or the industry faces new challenges.
Supply chain flexibility is of utmost importance for J&J, with operations in nearly every country of the world and products such as contact lenses, eye surgery tools and tuberculosis medicines. Their business structure relies upon Segments that connect each division through central functions as well as franchise management structures to carry out core elements of their businesses.
Sarfraz Nawaz, senior director for supply chain at Johnson & Johnson and head of its supply chain organization, discussed with PYMNTS how Johnson & Johnson’s digital transformation is helping it create more resilient supply chains in response to disruption. One method by which it adapts rapidly is through providing increased visibility and flexibility within manufacturing operations.
4. Sustainability
Johnson & Johnson has made sustainability the centerpiece of its operations, from production and packaging to energy acquisition and other resources. This dedication has garnered them numerous awards and honors such as being named Energy Star Partner of the Year by Energy Star and becoming members of Renewable Energy Buyers Alliance which sources sustainable sources for power. Furthermore, they have committed to reducing their carbon footprint while meeting 100% of their electricity requirements from renewables by 2024.
Johnson & Johnson is an iconic name in healthcare. They produce many everyday items we rely on – Band-Aids, Listerine mouthwash, Aveeno and Neutrogena skin care products, Visine eye drops and Tylenol pain relievers are just a few examples – as well as cutting-edge drugs, medical devices and surgical tools on the market today.
The company has managed to remain present in the global marketplace thanks to flexible and adaptable operating models that enable it to adapt to ever-evolving business environments by prioritizing internal innovation as well as acquiring companies poised for breakthrough in specific sectors.
Johnson & Johnson has demonstrated remarkable flexibility throughout its history and remains one of the cornerstones of the Dow Jones Industrial Average. By continually investing in innovative consumer health brands and developing new innovations across sectors, Johnson & Johnson is well positioned for future success and growth.
J&J has long been an innovator in corporate sustainability initiatives since their establishment, setting an example for other healthcare giants to follow. Their annual sustainability reports provide stakeholders with invaluable information regarding their efforts to make our world better, such as providing AIDS vaccines or supporting military veterans through veteran hiring programs. J&J stands as an exemplar of what a thriving family business can achieve when its employees and community come first.
